• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B7-H1和B7-DC与程序性死亡-1的差异结合特性

Differential binding properties of B7-H1 and B7-DC to programmed death-1.

作者信息

Youngnak Pornpan, Kozono Yuko, Kozono Haruo, Iwai Hideyuki, Otsuki Noriko, Jin Hisayo, Omura Ken, Yagita Hideo, Pardoll Drew M, Chen Lieping, Azuma Miyuki

机构信息

Department of Molecular Immunology, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8549, Japan.

出版信息

Biochem Biophys Res Commun. 2003 Aug 1;307(3):672-7. doi: 10.1016/s0006-291x(03)01257-9.

DOI:10.1016/s0006-291x(03)01257-9
PMID:12893276
Abstract

Programmed death-1 (PD-1) is a negative regulatory receptor expressed on activated T and B cells. Two ligands for PD-1, B7-H1 (PD-L1) and B7-DC (PD-L2), have been identified, but their binding properties have not been characterized yet. In this study, we generated soluble Ig fusion proteins of these molecules and examined the kinetics and relative affinities of the interactions between B7-H1 or B7-DC and PD-1 by flow cytometry and surface plasmon resonance. The interaction of B7-DC/PD-1 exhibited a 2-6-fold higher affinity and had different association/dissociation kinetics compared with the interaction of B7-H1/PD-1. Our results suggest that the differential binding properties of B7-H1 and B7-DC may be responsible for differential contributions of these two PD-1 ligands to immune responses.

摘要

程序性死亡蛋白1(PD-1)是一种在活化的T细胞和B细胞上表达的负性调节受体。已鉴定出PD-1的两种配体,即B7-H1(PD-L1)和B7-DC(PD-L2),但它们的结合特性尚未得到表征。在本研究中,我们制备了这些分子的可溶性Ig融合蛋白,并通过流式细胞术和表面等离子体共振检测了B7-H1或B7-DC与PD-1之间相互作用的动力学和相对亲和力。与B7-H1/PD-1的相互作用相比,B7-DC/PD-1的相互作用表现出高2至6倍的亲和力,并且具有不同的结合/解离动力学。我们的结果表明,B7-H1和B7-DC的不同结合特性可能是这两种PD-1配体对免疫反应的不同贡献的原因。

相似文献

1
Differential binding properties of B7-H1 and B7-DC to programmed death-1.B7-H1和B7-DC与程序性死亡-1的差异结合特性
Biochem Biophys Res Commun. 2003 Aug 1;307(3):672-7. doi: 10.1016/s0006-291x(03)01257-9.
2
Expression of programmed death 1 ligands by murine T cells and APC.小鼠T细胞和抗原呈递细胞程序性死亡1配体的表达
J Immunol. 2002 Nov 15;169(10):5538-45. doi: 10.4049/jimmunol.169.10.5538.
3
Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.阻断B7-H1可抑制慢性肠道炎症的发展。
J Immunol. 2003 Oct 15;171(8):4156-63. doi: 10.4049/jimmunol.171.8.4156.
4
Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine.通过局部基因治疗阻断程序性死亡-1配体与程序性死亡-1的相互作用可增强二级淋巴组织趋化因子的抗肿瘤作用。
J Immunol. 2004 Oct 15;173(8):4919-28. doi: 10.4049/jimmunol.173.8.4919.
5
B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts.B7-H1诱导的细胞凋亡作为角膜同种异体移植免疫赦免的一种机制。
J Immunol. 2006 Nov 1;177(9):5928-35. doi: 10.4049/jimmunol.177.9.5928.
6
Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.阻断树突状细胞上的程序性死亡-1配体可增强T细胞活化和细胞因子产生。
J Immunol. 2003 Feb 1;170(3):1257-66. doi: 10.4049/jimmunol.170.3.1257.
7
Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses.B7-H1对程序性死亡-1介导的半抗原特异性过敏性炎症反应调节的优先贡献。
Eur J Immunol. 2003 Oct;33(10):2773-82. doi: 10.1002/eji.200324084.
8
Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.抑制性受体PD-1的配体PD-L1和PD-L2在淋巴造血组织细胞中的差异表达。
Immunol Lett. 2002 Oct 21;84(1):57-62. doi: 10.1016/s0165-2478(02)00142-6.
9
Programmed death-1 targeting can promote allograft survival.程序性死亡-1靶向治疗可促进同种异体移植物存活。
J Immunol. 2002 Dec 1;169(11):6546-53. doi: 10.4049/jimmunol.169.11.6546.
10
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells.PD-1及其配体B7-H1在CD8 T细胞早期命运决定中的作用。
Blood. 2007 Jul 1;110(1):186-92. doi: 10.1182/blood-2006-12-062422. Epub 2007 Mar 28.

引用本文的文献

1
High PD-L2 Expression Is Associated with Better Disease-Free Survival in Patients with Intrahepatic Cholangiocarcinoma.高程序性死亡配体2(PD-L2)表达与肝内胆管癌患者更好的无病生存期相关。
Cancer Manag Res. 2025 Aug 20;17:1753-1766. doi: 10.2147/CMAR.S525958. eCollection 2025.
2
Negative Immune Checkpoint Inhibitors.阴性免疫检查点抑制剂
Pharmaceutics. 2025 May 28;17(6):713. doi: 10.3390/pharmaceutics17060713.
3
Integrative In Silico Analysis to Identify Functional and Structural Impacts of nsSNPs on Programmed Cell Death Protein 1 (PD-1) Protein and UTRs: Potential Biomarkers for Cancer Susceptibility.
整合计算机模拟分析以确定单核苷酸替换性非同义突变对程序性细胞死亡蛋白1(PD-1)及其非翻译区的功能和结构影响:癌症易感性的潜在生物标志物
Genes (Basel). 2025 Mar 4;16(3):307. doi: 10.3390/genes16030307.
4
Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence.免疫检查点抑制剂相关的皮肤不良事件:发生机制
Int J Mol Sci. 2024 Dec 26;26(1):88. doi: 10.3390/ijms26010088.
5
PD-L2 of tumor-derived exosomes mediates the immune escape of cancer cells via the impaired T cell function.肿瘤来源的外泌体中的 PD-L2 通过损伤 T 细胞功能介导癌细胞的免疫逃逸。
Cell Death Dis. 2024 Nov 7;15(11):800. doi: 10.1038/s41419-024-07191-7.
6
Noninvasive Monitoring of Programmed Death-Ligand 2 Expression with Positron Emission Tomography using Ga-labeled Peptide Antagonist in Preclinical and Exploratory Human Studies.在临床前和探索性人体研究中使用镓标记的肽拮抗剂通过正电子发射断层扫描对程序性死亡配体2表达进行无创监测。
Research (Wash D C). 2024 Nov 1;7:0523. doi: 10.34133/research.0523. eCollection 2024.
7
Review of T Helper 2-Type Inflammatory Diseases Following Immune Checkpoint Inhibitor Treatment.免疫检查点抑制剂治疗后2型辅助性T细胞炎症性疾病的综述
Biomedicines. 2024 Aug 19;12(8):1886. doi: 10.3390/biomedicines12081886.
8
Construction and preclinical evaluation of a I-labelled bispecific antibody targeting PD-L1 and PD-L2.构建并初步评估一种针对 PD-L1 和 PD-L2 的 I 型放射性标记双特异性抗体。
Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):36-47. doi: 10.1007/s00259-024-06886-5. Epub 2024 Aug 19.
9
Persistence of lung structural and functional alterations at one year post-COVID-19 is associated with increased serum PD-L2 levels and altered CD4/CD8 ratio.新冠病毒感染后一年,肺部结构和功能改变的持续存在与血清 PD-L2 水平升高和 CD4/CD8 比值改变有关。
Immun Inflamm Dis. 2024 Jul;12(7):e1305. doi: 10.1002/iid3.1305.
10
PD-L1 and PD-1 Are Associated with Clinical Outcomes and Alveolar Immune Cell Activation in Acute Respiratory Distress Syndrome.PD-L1 和 PD-1 与急性呼吸窘迫综合征的临床结局和肺泡免疫细胞激活相关。
Am J Respir Cell Mol Biol. 2024 Nov;71(5):534-545. doi: 10.1165/rcmb.2024-0201OC.